BMRN Financial Facts

Intangible asset amortization and contingent consideration: 8.96M
NET INCOME (LOSS) PER SHARE, DILUTED: -0.27
See Full Income Statement

Other current assets: 41.01M
Total liabilities and stockholders' equity: 2.34B
See Full Balance Sheet

BioMarin Pharmaceutical Inc. (BMRN) Earnings

  |   Expand Research on BMRN
Next EPS Date N/A EPS Growth Rate -48.4%
Average EPS % Beat Rate +20.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/21/13 Q412 -$0.43-$0.27 -$0.16$130.96M$129.7M = Details
2/16/12 Q411 -$0.23-$0.11 -$0.12$107.9M$115.3M = Details
10/24/13 Q313 -$0.38-$0.30 -$0.08$136.9M$140M = Details
4/26/12 Q112 -$0.21-$0.14 -$0.07$116.6M$119.24M = Details
8/1/12 Q212 -$0.27-$0.21 -$0.06$124M$121.54M = Details
4/25/13 Q113 -$0.31-$0.29 -$0.02N/A$131.44M = Details
4/28/11 Q111 -$0.04-$0.10 +$0.06$109.46M$103.8M Details
7/28/11 Q211 -$0.05-$0.11 +$0.06$110.63M$105.9M Details